Revision history of "ONCOLOGICAL IMMUNOTHERAPY BO-112: PRECLINICAL STUDIES OF THERAPEUTIC EFFICACY AND MOLECULAR MECHANISMS FOR THE DEFINITION OF THE PHASE OF CLINICAL EXPANSION AND PRODUCT CONSOLIDATION." (Q3170207)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

10 October 2024

  • curprev 09:4909:49, 10 October 2024DG Regio talk contribs 87,491 bytes −1 Changed label, description and/or aliases in pt
  • curprev 09:4909:49, 10 October 2024DG Regio talk contribs 87,492 bytes +13 Set a claim value: summary (P836): A Bioncotech é uma empresa biofarmacêutica espanhola que desde 2010 tem vindo a desenvolver um medicamento antitumoral enquadrado na área da imunoterapia do cancro, que hoje engloba as estratégias mais revolucionárias e promissoras na luta contra o cancro._x000D_ _x000D_ O primeiro composto desenvolvido pela Bioncotech, chamado BO-110, tem uma boa atividade terapêutica, particularmente em modelos de melanoma. Recentemente, a Bioncotech alterou o nom...

22 March 2024

20 December 2023

12 June 2023

10 June 2023

4 August 2022

  • curprev 10:2010:20, 4 August 2022DG Regio talk contribs 85,126 bytes +59,172 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

16 January 2022

17 December 2021

9 December 2021

4 December 2021

12 October 2021

  • curprev 17:3417:34, 12 October 2021DG Regio talk contribs 13,486 bytes +2,684 Created claim: summary (P836): Bioncotech is a Spanish bio-pharmaceutical company that since 2010 has been developing an anti-tumoral drug framed in the area of cancer immunotherapy, which today encompasses the most revolutionary and promising strategies in the fight against cancer._x000D_ _x000D_ The first compound developed by Bioncotech, called BO-110, has a good therapeutic activity, particularly in melanoma models. Recently, Bioncotech has made a change in the name of th...
  • curprev 17:3417:34, 12 October 2021DG Regio talk contribs 10,802 bytes −2,684 Removed claim: summary (P836): Bioncotech is a Spanish bio-pharmaceutical company that since 2010 has been developing an anti-tumoral drug framed in the area of cancer immunotherapy, which today encompasses the most revolutionary and promising strategies in the fight against cancer._x000D_ _x000D_ The first compound developed by Bioncotech, called BO-110, has a good therapeutic activity, particularly in melanoma models. Recently, Bioncotech has made a change in the name of...
  • curprev 16:4816:48, 12 October 2021DG Regio talk contribs 13,486 bytes +243 Changed label, description and/or aliases in en: translated_label
  • curprev 16:4816:48, 12 October 2021DG Regio talk contribs 13,243 bytes +2,684 Created claim: summary (P836): Bioncotech is a Spanish bio-pharmaceutical company that since 2010 has been developing an anti-tumoral drug framed in the area of cancer immunotherapy, which today encompasses the most revolutionary and promising strategies in the fight against cancer._x000D_ _x000D_ The first compound developed by Bioncotech, called BO-110, has a good therapeutic activity, particularly in melanoma models. Recently, Bioncotech has made a change in the name of th...

10 October 2021

9 October 2021

8 October 2021